Rein Therapeutics auditor Marcum resigns, CBIZ appointed; going concern noted

Rein Therapeutics, Inc.

Marcum LLP resigned as independent auditor on April 16, 2025; CBIZ CPAs P.C. engaged by Audit Committee.
Marcum's reports for 2024 and 2023 included a going concern explanatory paragraph for Rein Therapeutics.
No disagreements on accounting principles or practices between Marcum and the company.
Material weaknesses in internal controls over financial reporting were reported for both 2024 and 2023.
Company authorized Marcum to fully respond to successor auditor inquiries.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.